Growth and Differentiation Properties of Mesenchymal Stromal Cell Populations Derived from Whole Human Umbilical Cord

Stem Cell Reviews and Reports

Volumn 7, Issue 1, 2011, Pages 17-31

  Majore, Ingrida ^a   Moretti, Pierre ^a   Stahl, Frank ^a   Hass, Ralf ^b   Kasper, Cornelia ^a  

^a LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cytokine expression; Differentiation; Multipotent mesenchymal stromal cells; Proliferation; Umbilical cord

Indexed keywords

EID: 78751641526     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-010-9165-y     Document Type: Article

References (68)

1. Friedenstein, A. J., Piatetzky-Shapiro, I. I., & Petrakova, K. V. (1966). Osteogenesis in transplants of bone marrow cells. Journal of Embryology & Experimental Morphology, 16(3), 381-390.
2. Pittenger, M. F., Mackay, A. M., Beck, S. C., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143-147.
3. Dennis, J. E., Merriam, A., Awadallah, A., Yoo, J. U., Johnstone, B., & Caplan, A. I. (1999). A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. Journal of Bone and Mineral Research, 14, 700-709.
4. Choong, P. F., Mok, P. L., Cheong, S. K., Leong, C. F., & Then, K. Y. (2007). Generating neuron-like cells from BM-derived mesenchymal stromal cells in vitro. Cytotherapy, 9(2), 170-183.
5. Xu, R., Jiang, X., Guo, Z., et al. (2008). Functional analysis of neuron-like cells differentiated from neural stem cells derived from bone marrow stroma cells in vitro. Cellular and Molecular Neurobiology, 28(4), 545-558.
6. Sun, Y., Chen, L., Hou, X. G., et al. (2007). Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro. Chinese Medical Journal (Engl), 120(9), 771-776.
7. Saulnier, N., Lattanzi, W., Puglisi, M. A., et al. (2009). Mesenchymal stromal cells multipotency and plasticity: induction toward the hepatic lineage. European Review for Medical and Pharmacological Sciences, 13(1), 71-78.
8. Glennie, S., Soeiro, I., Dyson, P. J., Lam, E. W., & Dazzi, F. (2005). Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood, 105(7), 2821-2827.
9. Kode, J. A., Mukherjee, S., Joglekar, M. V., & Hardikar, A. A. (2009). Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy, 11(4), 377-391.
10. Siegel, G., Schäfer, R., & Dazzi, F. (2009). The immunosuppressive properties of mesenchymal stem cells. Transplantation, 87(9), 45-49.
11. Jones, E., & McGonagle, D. (2008). Human bone marrow mesenchymal stem cells in vivo. Rheumatology (Oxford), 47, 126-131.
12. Dominici, M., Le Blanc, K., Mueller, I., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy, 8, 315-317.
13. Hui, J. H., Ouyang, H. W., Hutmacher, D. W., Goh, J. C., & Lee, E. H. (2005). Mesenchymal stem cells in musculoskeletal tissue engineering: a review of recent advances in National University of Singapore. Annals of the Academy of Medicine, Singapore, 34(2), 206-212.
14. Kraus, K. H., & Kirker-Head, C. (2006). Mesenchymal stem cells and bone regeneration. Veterinary Surgery, 35(3), 232-242.
15. Mobasheri, A., Csaki, C., Clutterbuck, A. L., Rahmanzadeh, M., & Shakibaei, M. (2009). Mesenchymal stem cells in connective tissue engineering and regenerative medicine: applications in cartilage repair and osteoarthritis therapy. Histology and Histopathology, 24(3), 347-366.
16. Syková, E., Jendelová, P., Urdzíková, L., Lesný, P., & Hejcl, A. (2006). Bone marrow stem cells and polymer hydrogels-two strategies for spinal cord injury repair. Cellular and Molecular Neurobiology, 26(7-8), 1113-1129.
17. Perin E. (2004). Transendocardial injection of autologous mononuclear bone marrow cells in end-stage ischemic heart failure patients: one-year follow-up. International Journal of Cardiology, 95(Suppl 1), S45-S46.
18. Stamm, C., Kleine, H. D., Westphal, B., et al. (2004). CABG and bone marrow stem cell transplantation after myocardial infarction. Thoracic and Cardiovascular Surgeon, 52(3), 152-158.
19. Lazarus, H. M., Koc, O. N., Devine, S. M., et al. (2005). Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biology of Blood and Marrow Transplantation, 11(5), 389-398.
20. Fouillard, L., Chapel, A., Bories, D., et al. (2007). Infusion of allogeneic-related HLA mismatched mesenchymal stem cells for the treatment of incomplete engraftment following autologous haematopoietic stem cell transplantation. Leukemia, 21(3), 568-570.
21. Horwitz, E. M., Prockop, D. J., Gordon, P. L., et al. (2001). Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood, 97(5), 1227-1231.
22. Le Blanc, K., Rasmusson, I., Sundberg, B., et al. (2004). Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet, 363(9419), 1439-1441.
23. Ringdén, O., Uzunel, M., Rasmusson, I., et al. (2006). Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation, 81(10), 1390-1397.
24. Majumdar, M. K., Thiede, M. A., Haynesworth, S. E., Bruder, S. P., & Gerson, S. L. (2000). Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. Journal of Hematotherapy & Stem Cell Research, 9(6), 841-848.
25. Caplan, A. I., & Dennis, J. E. (2006). Mesenchymal stem cells as trophic mediators. Journal of Cellular Biochemistry, 98(5), 1076-1084.
26. Lda Meirelles, S., Fontes, A. M., Covas, D. T., & Caplan, A. I. (2009). Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine & Growth Factor Reviews, 20(5-6), 419-427.
27. Pittenger, M. F., Mackay, A. M., Beck, S. C., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284(5411), 143-147.
28. Caplan, A. I. (2009). Why are MSCs therapeutic? New data: new insight. The Journal of Pathology, 217(2), 318-324.
29. Kuo, C. K., Li, W. J., Mauck, R. L., & Tuan, R. S. (2006). Cartilage tissue engineering: its potential and uses. Current Opinion in Rheumatology, 18(1), 64-73.
30. da Silva Meirelles, L., Chagastelles, P. C., & Nardi, N. B. (2006). Mesenchymal stem cells reside in virtually all post-natal organs and tissues. Journal of Cell Science, 119(Pt 11), 2204-2213.
31. Marcus, A. J., & Woodbury, D. (2008). Fetal stem cells from extra-embryonic tissues: do not discard. Journal of Cellular and Molecular Medicine, 12(3), 730-742.
32. Baksh, D., Yao, R., & Tuan, R. S. (2007). Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells, 25, 1384-1392.
33. Can, A., & Karahuseyinoglu, S. (2007). Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells, 25(11), 2886-2895.
34. Weiss, M. L., & Troyer, D. L. (2008). Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells, 26(3), 591-599.
35. Kita, K., Gauglitz, G. G., Phan, T. T., Herndon, D. N., Jeschke, M. G. (2009). Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane. Stem Cells Dev, Jul 27, [Epub ahead of print].
36. Covas, D. T., Siufi, J. L., Silva, A. R., & Orellana, M. D. (2003). Isolation and culture of umbilical vein mesenchymal stem cells. Brazilian Journal of Medical and Biological Research, 36, 1179-1183.
37. Sarugaser, R., Lickorish, D., Baksh, D., Hosseini, M. M., & Davies, J. E. (2005). Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells, 23, 220-229.
38. Weiss, M. L., Medicetty, S., & Bledsoe, A. R. (2006). Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells, 24(3), 781-792.
39. La Rocca, G., Anzalone, R., Corrao, S., et al. (2009). Isolation and characterization of Oct-4+/HLA-G + mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochemistry and Cell Biology, 131, 267-282.
40. Brockhoff, G. (2007). Grundlagen, Methoden und klinische Anwendungen der Durchflusszytometrie. In U. Sack, A. Tárnok, & G. Rothe (Eds.), Zelluläre Diagnostik (Vol. 1, pp. 604-646). Basel: Karger.
41. Majore, I., Moretti, P., Hass, R., Kasper, C. (2009). Identification of subpopulations in mesenchymal stem cell-like cultures from human umbilical cord. Cell Commun Signal. http://www. biosignaling. com/content/7/1/6. Accessed 20 March 2009.
42. Martinez, C., Hofmann, T. J., Marino, R., Dominici, M., & Horwitz, E. M. (2007). Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs. Blood, 109(10), 4245-4248.
43. Tsutsumi, S., Shimazu, A., Miyazaki, K., et al. (2001). Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochemical and Biophysical Research Communications, 288(2), 413-419.
44. Bianchi, G., Banfi, A., Mastrogiacomo, M., et al. (2003). Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Experimental Cell Research, 287(1), 98-105.
45. Thomson, J. A., Itskovitz-Eldor, J., Sander, S., et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282(5391), 1145-1147.
46. Gronthos, S., Fitter, S., Diamond, P., et al. (2007). A novel monoclonal antibody (STRO-3) identifies an isoform of tissue nonspecific alkaline phosphatase expressed by multipotent bone marrow stromal stem cells. Stem Cells and Development, 16(6), 953-963.
47. Qiao, C., Xu, W., Zhu, W., Hu, J., Qian, H., Yin, Q., et al. (2008). Human mesenchymal stem cells isolated from the umbilical cord. Cell Biology International, 32, 8-15.
48. Zhang, Z. Y., Teoh, S. H., Chong, M. S., Schantz, J. T., Fisk, N. M., Choolani, M. A., et al. (2009). Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells. Stem Cells, 27, 126-137.
49. Raval, A., Puri, N., Rath, P. C., & Saxena, R. K. (1998). Cytokine regulation of expression of class I MHC antigens. Experimental & Molecular Medicine, 30(1), 1-13.
50. Wang, H. S., Hung, S. C., Peng, S. T., Huang, C. C., Wei, H. M., Guo, Y. J., et al. (2004). Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells, 22, 1330-1337.
51. Jo, C. H., Kim, O. S., Park, E. Y., Kim, B. J., Lee, J. H., Kang, S. B., et al. (2008). Fetal mesenchymal stem cells derived from human umbilical cord sustain primitive characteristics during extensive expansion. Cell and Tissue Research, 334, 423-433.
52. Sarugaser, R., Ennis, J., Stanford, W. L., & Davies, J. E. (2009). Isolation, propagation, and characterization of human umbilical cord perivascular cells (HUCPVCs). Methods in Molecular Biology, 482, 269-279.
53. Chung, C., & Burdick, J. A. (2009). Influence of three-dimensional hyaluronic acid microenvironments on mesenchymal stem cell chondrogenesis. Tissue Engineering. Part A, 15(2), 243-254.
54. Wu, S. C., Chang, J. K., Wang, C. K., Wang, G. J., & Ho, M. L. (2010). Enhancement of chondrogenesis of human adipose derived stem cells in a hyaluronan-enriched microenvironment. Biomaterials, 31(4), 631-640.
55. Diao, Y., Ma, Q., Cui, F., & Zhong, Y. (2008). Human umbilical cord mesenchymal stem cells: Osteogenesis in vivo as seed cells for bone tissue engineering. Journal of Biomedical Materials Research. Part A, 91(1), 123-131.
56. Hou, T., Xu, J., Wu, X., et al. (2009). Umbilical cord Wharton's Jelly: a new potential cell source of mesenchymal stromal cells for bone tissue engineering. Tissue Engineering. Part A, 15(9), 2325-2334.
57. Suzdal'tseva, Y. G., Burunova, V. V., Vakhrushev, I. V., Yarygin, V. N., & Yarygin, K. N. (2007). Capability of human mesenchymal cells isolated from different sources to differentiation into tissues of mesodermal origin. Bulletin of Experimental Biology and Medicine, 143, 114-121.
58. Girdlestone, J., Limbani, V. A., Cutler, A. J., & Navarrete, C. V. (2009). Efficient expansion of mesenchymal stromal cells from umbilical cord under low serum conditions. Cytotherapy, 11(6), 738-748.
59. Ishige, I., Nagamura-Inoue, T., Honda, M. J., et al. (2009). Comparison of mesenchymal stem cells derived from arterial, venous, and Wharton's jelly explants of human umbilical cord. International Journal of Hematology, 90(2), 261-269.
60. Horwitz, E. M., Le Blanc, K., Dominaci, M., et al. (2005). Clarification of the nomenclature for MSC: The international society for cellular therapy position statement. Cytotherapy, 7(5), 393-395.
61. Suva, D., Garavaglia, G., Menetrey, J., et al. (2004). Non-hematopoietic human bone marrow contains long-lasting, pluripotential mesenchymal stem cells. Journal of Cellular Physiology, 198(1), 110-118.
62. Rubio, D., Garcia-Castro, J., Martín, M. C., et al. (2005). Spontaneous human adult stem cell transformation. Cancer Research, 65(8), 3035-3039.
63. Battiwalla, M., & Hematti, P. (2009). Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy, 11(5), 503-515.
64. Colter, D. C., Sekiya, I., & Prockop, D. J. (2001). Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proceedings of the National Academy of Sciences of the United States of America, 98(14), 7841-7845.
65. Sotiropoulou, P. A., Perez, S. A., Salagianni, M., Baxevanis, C. N., & Papamichail, M. (2006). Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells, 24(2), 462-471.
66. Małkowski, A., Sobolewski, K., Jaworski, S., & Bańkowski, E. (2008). TGF-beta binding in human Wharton's jelly. Molecular and Cellular Biochemistry, 311(1-2), 137-143.
67. Lu, L. L., Liu, Y. J., Yang, S. G., et al. (2006). Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica, 91(8), 1017-1026.
68. Hiroyama, T., Sudo, K., Aoki, N., et al. (2008). Human umbilical cord-derived cells can often serve as feeder cells to maintain primate embryonic stem cells in a state capable of producing hematopoietic cells. Cell Biology International, 32(1), 1-7.